LONDON, Jan. 10, 2024 Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the appointment of Robert W..
Progress in the market is also being aided by an increase in research on non-steroidal anti-inflammatory drugs (NSAIDs) and a rise in patient knowledge of the advantages of drugs.Wilmington, Delaware, United States, Dec. 15, 2023 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The global cancer cachexia market was projected to attain US$ 2.2 billion in 2022. It is anticipated to garner a 4.7% CAGR from 2023 to 2031. By 2031, the market is likely to attain US$ 3.6 billion by 2031. Researc
Form 8-K Tourmaline Bio, Inc. For: Dec 13 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SEATTLE, November 02, 2023 ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for cancer, today announced the addition of multiple industry veterans to its leadership team to support its growth.
Congenital Adrenal Hyperplasia Treatment Market Worth US$ 892 Million By Year 2033 | Future Market Insights, Inc. menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.